Dr. MaryAnne Armstrong
Birch, Stewart, Kolasch & Birch, LLP
8110 Gatehouse Road
Suite 100 East
Falls Church, 22042-1248
United States
MaryAnne Armstrong has a bachelor’s degree in biochemistry from the Pennsylvania State University and a Ph.D. in biochemistry, with a master’s degree in immunology, both from Cornell University. Dr. Armstrong worked as a post-doctoral fellow in the Laboratory of Experimental Immunology, National Cancer Institute, NIH. She has practiced in the intellectual property field since 1995, working with both large and small companies and universities, for the preparation and prosecution of patent applications in the fields of immunology, pharmaceutical chemistry, biotechnology, vaccines, therapeutic antibodies, organic chemistry, assay and drug screening systems, medical devices and plant patents.
MaryAnne Armstrong has a bachelor’s degree in biochemistry from the Pennsylvania State University and a Ph.D. in biochemistry, with a master’s degree in immunology, both from Cornell University. Dr. Armstrong worked as a post-doctoral fellow in the Laboratory of Experimental Immunology, National Cancer Institute, NIH. She has practiced in the intellectual property field since 1995, working with both large and small companies and universities, for the preparation and prosecution of patent applications in the fields of immunology, pharmaceutical chemistry, biotechnology, vaccines, therapeutic antibodies, organic chemistry, assay and drug screening systems, medical devices and plant patents.
Dr. Armstrong is experienced in post-grant procedures, including inter partes review and interference practices. Dr. Armstrong successfully represented a third party requestor in the inter partes reexamination invalidation of a patent through the Court of Appeals for the Federal Circuit (CAFC) and successfully represented the petitioner in the invalidation of three biologics patents in IPR proceedings. Dr. Armstrong has considerable experience in counseling clients with regard to FTO opinions based on infringement and/or validity analysis, as well as counseling clients with regard to patentability analyses and the preparation of license agreements and collaboration agreements. She is also experienced in FDA related procedures, including ANDAs and requests for Patent Term Extension.
Roles in FICPI
-
CET 3 International Patent Matters
CET Group 3 focuses on developments of the international patent system and provides guidance to its users. Such developments can relate to both substantive and procedural aspects of patent law, and CET3 follows them across jurisdictions.
CET3 identifies issues that deserve study, conducts the studies and provides guidance through various outputs available to the users of the patent system such as Guidelines, Position papers, and Resolutions. CET3 actively contributes to forging and advocating the position of FICPI in discussions on patent law harmonisation in key study and discussion groups such as the Group B+ and at the forums established by WIPO.
CET3 also monitors and studies international agreements and conventions relating to patents, follows the developments of the PCT system and, where necessary, provides comments to WIPO and relevant authorities for defending a well-balanced international patent system.
- Reporter
DEIA Committee
- Member